CovInnovations
The new standard of COVID-19 solutions.
Overview
Raised: $4,297
Rolling Commitments ($USD)
02/14/2023
$74
8
2021
Healthcare & Pharmaceuticals
HealthTech
B2B
Medium
High
Summary Profit and Loss Statement
FY 2021 | FY 2020 | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-831,753 |
$0 |
Summary Balance Sheet
FY 2021 | FY 2020 | |
---|---|---|
Cash |
$2,127 |
$0 |
Accounts Receivable |
$72,348 |
$0 |
Total Assets |
$74,476 |
$0 |
Short-Term Debt |
$296,233 |
$0 |
Long-Term Debt |
$609,996 |
$0 |
Total Liabilities |
$906,229 |
$0 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual